DeepMed Research

UNIVERSITY OF CALIFORNIA SAN DIEGO

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1960-11-18

Employees: 10K

Market Cap: -

Website: http://www.ucsd.edu

Clinical Trials

Directed Use of REmote Patient Management System AMia to Achieve Prescribed Dry Weight

Not Applicable

Active, not recruiting

Conditions: Efficacy
Safety Issues

Interventions: Combination Product: AMIA with SHARESOURCE Connectivity Platform
Device: HomeChoice PRO

First Posted Date: 2019-06-28

Last Posted Date: 2021-08-25

Lead Sponsor: University of California, San Diego

Target Recruit Count: 28

Registration Number: NCT04002440

Locations: 🇺🇸
Home Dialysis Therapies of San Diego, San Diego, California, United States

Tadalafil and Pembrolizumab in Recurrent or Metastatic Head and Neck Cancer

Phase 2

Active, not recruiting

Conditions: Head and Neck Cancer
Cancer of Head and Neck
Cancer of Neck
Head and Neck Squamous Cell Carcinoma
Head and Neck Carcinoma
Head and Neck Cancer Stage III
Head and Neck Cancer Stage IV
Cancer
Head and Neck Cancer Metastatic
Cancer, Metastatic

Interventions: Drug: Pembrolizumab
Drug: Tadalafil

First Posted Date: 2019-06-20

Last Posted Date: 2024-11-18

Lead Sponsor: University of California, San Diego

Target Recruit Count: 7

Registration Number: NCT03993353

Locations: 🇺🇸
UCSD Moores Cancer Center, La Jolla, California, United States

Pilot Study of the IL-1 Antagonist Anakinra for the Treatment of Endometriosis Related Symptoms

Early Phase 1

Conditions: Markers of Inflammation
Endometriosis
Anakinra

Interventions: Drug: Anakinra 100Mg/0.67Ml Inj Syringe
Drug: Placebo

First Posted Date: 2019-06-19

Last Posted Date: 2021-05-28

Lead Sponsor: University of California, San Diego

Target Recruit Count: 20

Registration Number: NCT03991520

Locations: 🇺🇸
UCSD Reproductive Endocrinology, La Jolla, California, United States

Inferior Vena Cava (IVC) Diameters Before & After Interscalene Block

Withdrawn

Conditions: IVC - Inferior Vena Cava Abnormality

First Posted Date: 2019-06-18

Last Posted Date: 2021-07-21

Lead Sponsor: University of California, San Diego

Registration Number: NCT03989076

Locations: 🇺🇸
UCSD Medical Center, La Jolla, California, United States

Characteristics and Inflammatory Markers in Children with Eosinophilic Esophagitis (EoE)

Recruiting

Conditions: Eosinophilic Esophagitis

First Posted Date: 2019-06-10

Last Posted Date: 2024-11-25

Lead Sponsor: University of California, San Diego

Target Recruit Count: 1500

Registration Number: NCT03980886

Locations: 🇺🇸
Rady Children's Hospital San Diego, San Diego, California, United States

Contraception for Solid Organ Transplant Patients: Utilizing Social Media

Completed

Conditions: Contraception
Contraception Behavior
Contraceptive Usage
Reproductive Health

First Posted Date: 2019-06-10

Last Posted Date: 2023-03-31

Lead Sponsor: University of California, San Diego

Target Recruit Count: 52

Registration Number: NCT03979950

Locations: 🇺🇸
University of California, San Diego, La Jolla, California, United States

An Open Label Navigational Investigation of Molecular Profile-Related Evidence Determining Individualized Cancer Therapy for Patients With Incurable Hematologic Malignancies (I-PREDICT Heme)

Terminated

Conditions: Hematologic Cancer

Interventions: Other: Molecularly targeted treatment matched to genomic/immunophenotypic tumor profile (chosen by treating physician)

First Posted Date: 2019-05-20

Last Posted Date: 2022-02-15

Lead Sponsor: University of California, San Diego

Target Recruit Count: 13

Registration Number: NCT03955276

Locations: 🇺🇸
UCSD Moore's Cancer Center, La Jolla, California, United States

Measuring Plasticity in SFC/dACC Following Theta-Burst-Stimulation Using TMS

Not Applicable

Completed

Conditions: Cognitive Control

Interventions: Device: cTBS then iTBS
Device: iTBS then cTBS

First Posted Date: 2019-05-10

Last Posted Date: 2021-03-09

Lead Sponsor: University of California, San Diego

Target Recruit Count: 25

Registration Number: NCT03946059

Locations: 🇺🇸
Altman Clinical & Translational Research Institute, La Jolla, California, United States

Study Comparing the Effects of Latanoprostene Bunod and Timolol on Retinal Blood Vessel Density and Visual Acuity

Not Applicable

Completed

Conditions: OHT - Ocular Hypertension
OAG - Open-Angle Glaucoma

Interventions: Drug: Latanoprostene bunod 0.024% QD
Drug: Timolol maleate 0.5% BID

First Posted Date: 2019-04-30

Last Posted Date: 2023-08-29

Lead Sponsor: University of California, San Diego

Target Recruit Count: 70

Registration Number: NCT03931317

Locations: 🇺🇸
UCSD Shiley Eye Institute, La Jolla, California, United States

Metabolic Pathways of GRA in Patients With Type 1 Diabetes

Phase 1

Completed

Conditions: Type 1 Diabetes Mellitus

Interventions: Drug: REMD-477

First Posted Date: 2019-04-18

Last Posted Date: 2022-07-15

Lead Sponsor: University of California, San Diego

Target Recruit Count: 4

Registration Number: NCT03919617

Locations: 🇺🇸
UC San Diego Altman Clinical & Translational Research Institute, La Jolla, California, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy